Show simple item record

dc.contributor.advisorPaula T. Hammond and Darrell J. Irvine.en_US
dc.contributor.authorZmolek, Andrew Charlesen_US
dc.contributor.otherMassachusetts Institute of Technology. Department of Chemical Engineering.en_US
dc.date.accessioned2018-04-27T18:10:17Z
dc.date.available2018-04-27T18:10:17Z
dc.date.copyright2017en_US
dc.date.issued2017en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/115019
dc.descriptionThesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, 2017.en_US
dc.descriptionCataloged from PDF version of thesis.en_US
dc.descriptionIncludes bibliographical references (pages 105-113).en_US
dc.description.abstractThe poor efficacy of subunit protein vaccines, which typically consist of a protein antigen and a molecular adjuvant, has recently been improved by completing multiple injections of the vaccine with an exponential dosing profile over time. The hypothesis is that as viruses replicate in a host organism, they shed exponentially increasing quantities of pathogen associated molecular patterns (PAMPs) and viral protein, and replicating this pattern during vaccination allows scientists to better mimic the immune response elicited by an actual infection. Instead of completing multiple injections, a promising alternative is to complete a one-time application of a microneedle device to the skin that controllably releases the vaccine to mimic this exponential pattern to manipulate the immune system into providing strong humoral and cellular mediated protection. A number of different novel microneedle constructs have been created in this thesis towards this end. Membrane microneedles consist of tips with a polymeric core that contains vaccine that's encapsulated within a crosslinked layer-by-layer film. The three component film acts as a tunable diffusional barrier to vaccine release. Poly([gamma]-propargyl 1-glutamate) (PPLG) polymer grafted with maleimides was used to make microneedles that function based on the same concept except that the tip's surfaces are chemically crosslinked with poly(ethylene glycol) dithiol to enable controlled release. Importantly, degradable ester bonds are incorporated into the network to allow for tunability. Finally, poly(vinyl alcohol) microneedles were vapor-phase crosslinked to form reversible acetal bonds, and these constructs were also characterized and shown to allow for controlled release. Several other constructs were also generated. The work presented herein involves the microneedle design, fabrication, and characterization of these constructs with various experimental set-ups and techniques.en_US
dc.description.statementofresponsibilityby Andrew Charles Zmolek.en_US
dc.format.extent113 pagesen_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsMIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectChemical Engineering.en_US
dc.titleControlled release microneedle technologies for the enhanced immunogenicity of subunit vaccinesen_US
dc.typeThesisen_US
dc.description.degreePh. D.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineering
dc.identifier.oclc1030147775en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record